Gynecology: When the Law Worked
Another scare about a new birthcontrol pill set U.S. doctors' telephones jangling last week as women called to ask whether their particular pills were safe. The answer was the same as it has been since the pills first went on the market in 1960: "Yes, as far as anyone knows."
The facts in the current case were simple and clear. Merck Sharp & Dohme was testing a pill containing two synthetic hormones. One is an estrogen, familiar and long in use; the second is a new progestin, closely related to those in pills already available but differing in detailed chemical structure. Although 340 women have taken the still-experimental pill for several months with no apparent ill effects, the manufacturer tried giving exceptionally large doses20 to 40 times the human doseto dogs. Two of the dogs in the experiment developed cancer.
As required by 1962 law, Merck promptly notified the Food and Drug Administration and simultaneously asked physicians to stop testing the pills. Commented an FDA spokesman: "It seems clear that this is a case where the law worked the way it was supposed to."
Most Popular »
- Sex, Please, We're British: London's Erotica Expo
- The Growing Backlash Against Overparenting
- Toilets
- Woman Loses Benefits over Facebook Photo
- Talking with the Taliban: Easier Said Than Done
- East Antarctica, Long Stable, Is Now Losing Ice
- Is This the End of the Line for Saab?
- The Fall of Greg Craig, Obama's Top Lawyer
- Why Exercise Won't Make You Thin
- Super-Crocodiles May Have Dined on Dinosaurs
- The Growing Backlash Against Overparenting
- Sex, Please, We're British: London's Erotica Expo
- Will Private Equity Be the Next Meltdown?
- Toilets
- Why Exercise Won't Make You Thin
- Singh in Washington: Making the Case for India
- Spanish Outraged by Teen Masturbation Workshops
- Reburying Albert Camus: A Political Ploy by Sarkozy?
- The Dark Side of Darwin's Legacy
- Troubling Rise of Facebook's Top Game Company







RSS